生物活性试剂 DMTr-LNA-5MeU-3-CED-phosphoramidite 是一种核苷衍生物。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 1-[(1R,4R,6R,7S)-4-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-6-yl]-5-methylpyrimidine-2,4-dione | 206055-71-2 | C32H32N2O8 | 572.615 |
—— | (1S,3R,4R,7S)-7-(benzyloxy)-1-[(benzyloxy)methyl]-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane | 206055-62-1 | C25H26N2O6 | 450.491 |
—— | (1S,3R,4R,7S)-7-benzyloxy-1-hydroxymethyl-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane | 212970-84-8 | C18H20N2O6 | 360.367 |
—— | (1R,3R,4R,7S)-1-benzoyloxymethyl-7-benzyloxy-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane | 391199-74-9 | C25H24N2O7 | 464.475 |
—— | (1R,3R,4R,7S)-7-benzyloxy-1-methanesulfonoxymethyl-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane | 293751-05-0 | C19H22N2O8S | 438.458 |
—— | 1-[(2R,3R,4S,5R)-4-benzyloxy-5-(benzyloxymethyl)-3-hydroxy-5-(hydroxymethyl)tetra-hydrofuran-2-yl]-5-methylpyrimidine-2,4-dione | 206055-57-4 | C25H28N2O7 | 468.507 |
1-(2’-O,4-C-甲桥-beta-D-呋喃核糖基)胸腺嘧啶 | (1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane | 206055-67-6 | C11H14N2O6 | 270.242 |
—— | 3'-O-benzyl-2'-O,4'-C-methyleneuridine | 200435-91-2 | C17H18N2O6 | 346.34 |
—— | 2',3'-O-cyclohexylidene-4'-(p-toluenesulfonyloxymethyl)uridine | 195705-07-8 | C23H28N2O9S | 508.549 |
—— | 3'-O-benzyl-4'-(p-toluenesulfonyloxymethyl)uridine | 200435-89-8 | C24H26N2O9S | 518.544 |
1-(2’-O,4-C-甲桥-BETA-D-呋喃核糖基)尿苷 | 2'-O,4'-C-methyleneuridine | 200435-92-3 | C10H12N2O6 | 256.215 |
—— | O2',O3'-cyclohexane-1,1-diyl-4'-hydroxymethyl-uridine | 63592-89-2 | C16H22N2O7 | 354.36 |
—— | 4'-(p-toluenesulfonyl)oxymethyluridine | 195705-15-8 | C17H20N2O9S | 428.42 |
The 3′-end sugar puckering of a dinucleotide can potentiate or cancel the stacking effect of the 5′-end N-sugar conformation.